| Ruthenium (II)–arene RAPTA type complexes containing curcumin and bisdemethoxycurcumin display potent and selective anticancer activity R Pettinari, F Marchetti, F Condello, C Pettinari, G Lupidi, R Scopelliti, ... Organometallics 33 (14), 3709-3715, 2014 | 207 | 2014 |
| Fighting cancer with transition metal complexes: from naked DNA to protein and chromatin targeting strategies G Palermo, A Magistrato, T Riedel, T Von Erlach, CA Davey, PJ Dyson, ... ChemMedChem 11 (12), 1199-1210, 2016 | 132 | 2016 |
| Ruthenium (II) and osmium (II) 1, 2, 3-triazolylidene organometallics: a preliminary investigation into the biological activity of ‘click’carbene complexes KJ Kilpin, S Crot, T Riedel, JA Kitchen, PJ Dyson Dalton Transactions 43 (3), 1443-1448, 2014 | 114 | 2014 |
| Allosteric cross-talk in chromatin can mediate drug-drug synergy Z Adhireksan, G Palermo, T Riedel, Z Ma, R Muhammad, U Rothlisberger, ... Nature communications 8 (1), 14860, 2017 | 88 | 2017 |
| Synthesis of triazenes with nitrous oxide G Kiefer, T Riedel, PJ Dyson, R Scopelliti, K Severin Angewandte Chemie International Edition 54 (1), 302-305, 2015 | 84 | 2015 |
| Engineered synthetic virus‐like particles and their use in vaccine delivery A Ghasparian, T Riedel, J Koomullil, K Moehle, C Gorba, DI Svergun, ... ChemBioChem 12 (1), 100-109, 2011 | 76 | 2011 |
| Synthesis, structure, and anticancer activity of arene–ruthenium (II) complexes with acylpyrazolones bearing aliphatic groups in the acyl moiety J Palmucci, F Marchetti, R Pettinari, C Pettinari, R Scopelliti, T Riedel, ... Inorganic chemistry 55 (22), 11770-11781, 2016 | 74 | 2016 |
| Synthesis and antiproliferative activity of new ruthenium complexes with ethacrynic-acid-modified pyridine and triphenylphosphine ligands G Agonigi, T Riedel, S Zacchini, E Paunescu, G Pampaloni, N Bartalucci, ... Inorganic chemistry 54 (13), 6504-6512, 2015 | 70 | 2015 |
| New class of half-sandwich ruthenium (II) arene complexes bearing the water-soluble CAP ligand as an in vitro anticancer agent A Guerriero, W Oberhauser, T Riedel, M Peruzzini, PJ Dyson, L Gonsalvi Inorganic chemistry 56 (10), 5514-5518, 2017 | 68 | 2017 |
| Organometallic rhodium (III) and iridium (III) cyclopentadienyl complexes with curcumin and bisdemethoxycurcumin co-ligands R Pettinari, F Marchetti, C Pettinari, F Condello, A Petrini, R Scopelliti, ... Dalton Transactions 44 (47), 20523-20531, 2015 | 68 | 2015 |
| Synthesis and evaluation of new polynuclear organometallic Ru (II), Rh (III) and Ir (III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents P Chellan, KM Land, A Shokar, A Au, SH An, D Taylor, PJ Smith, T Riedel, ... Dalton Transactions 43 (2), 513-526, 2014 | 66 | 2014 |
| Strategy to optimize the biological activity of arene ruthenium metalla-assemblies A Garci, AA Dobrov, T Riedel, E Orhan, PJ Dyson, VB Arion, B Therrien Organometallics 33 (14), 3813-3822, 2014 | 49 | 2014 |
| Synthetic virus‐like particles and conformationally constrained peptidomimetics in vaccine design T Riedel, A Ghasparian, K Moehle, P Rusert, A Trkola, JA Robinson Chembiochem 12 (18), 2829-2836, 2011 | 49 | 2011 |
| Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation GE Davey, Z Adhireksan, Z Ma, T Riedel, D Sharma, S Padavattan, ... Nature communications 8 (1), 1575, 2017 | 48 | 2017 |
| From sunscreen to anticancer agent: Ruthenium (II) arene avobenzone complexes display potent anticancer activity R Pettinari, F Marchetti, A Petrini, C Pettinari, G Lupidi, P Smolenski, ... Organometallics 35 (21), 3734-3742, 2016 | 48 | 2016 |
| Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: Synthesis, cytotoxicity and DNA binding studies P Govender, T Riedel, PJ Dyson, GS Smith Dalton Transactions 45 (23), 9529-9539, 2016 | 48 | 2016 |
| Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer A Bergamo, T Riedel, PJ Dyson, G Sava Investigational new drugs 33 (1), 53-63, 2015 | 48 | 2015 |
| Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors A Mann, N Friedrich, A Krarup, J Weber, E Stiegeler, B Dreier, P Pugach, ... Journal of virology 87 (10), 5868-5881, 2013 | 45 | 2013 |
| Cytotoxic half-sandwich Rh (III) and Ir (III) β-diketonates A Petrini, R Pettinari, F Marchetti, C Pettinari, B Therrien, A Galindo, ... Inorganic chemistry 56 (21), 13600-13612, 2017 | 43 | 2017 |
| Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study RFS Lee, T Riedel, S Escrig, C Maclachlan, GW Knott, CA Davey, ... Metallomics 9 (10), 1413-1420, 2017 | 40 | 2017 |
